Online Pathway for Depression in Cancer Patients (iPath*D)
This study is testing an online tool called iPath*D, which helps cancer patients who are also experiencing symptoms of depression. The goal is to see how well this online pathway works to connect patients with depression screening, information, and treatment options. Researchers want to know if iPath*D is easy to use and helpful for patients. You might be able to join if you are an adult (18 or older) starting cancer treatment at Dartmouth Cancer Center North, can speak English, and have moderate depression symptoms (PHQ-9 score between 10 and 27). The study aims to enroll 30 participants.
- Study design
- This is an open-label, single-arm pilot study involving 30 adult patients. It is not specified which phase of testing this study is in.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main study goals (usability, acceptability, and feasibility) are measured at 2 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Paul Barr, Ph.D. · PRINCIPAL_INVESTIGATOR · Dartmouth College
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- System usability2 weeks
System Usability Scale (10 items; mean ≥68/100),
- Acceptability of intervention2 weeks
Acceptability of Intervention Measure (4 items), mean ≥4/5
- Feasibility of intervention2 weeks
Feasibility of Intervention Measure (4 items), mean ≥4/5
- Change in number of patients selecting a treatment path to access2 weeks, 4 weeks, 6 weeks
Click on link to access online treatment service \| indicate in self-report survey accessing local resources
- Change in Mental Health Literacy (MHL)Baseline, 2 weeks
A modified 10-item version for the validated multiple choice questionnaire (MCQ) for depression assesses treatment knowledge, understanding \& beliefs. Higher scores indicate higher MHL.